メラノーマ・母斑の診断アトラス

出版社： 文光堂
著者：
発行日： 2014-11-01
分野： 臨床医学：内科  >  皮膚科
ISBN： 9784830634604
電子書籍版： 2014-11-01 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

17,600 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

17,600 円(税込)

購入する

商品紹介

多数の臨床・ダーモスコピー・病理組織写真を掲載し，メラノーマ・母斑の基礎知識，診断のしかたをわかりやすく記載している．この1冊でメラノーマ診断の全てを身につけることができる．

目次

  • メラノーマ・母斑の診断アトラス

    ―目次―

    A メラノーマと色素細胞母斑の本態・分類・診断
    　?． メラノーマの組織発生と病型
    　II． 色素細胞母斑の組織発生と分類
    　III． メラノーマの診断法：手順とポイント

    B メラノーマの診断演習
    　I．臨床・ダーモスコピー診断
    　II． 病理組織診断

    C 症例検討会
    　I．Ackerman先生の症例検討会（10症例）
    　II． 紙上症例検討会（8症例）

    D 母斑とメラノーマの遺伝子異常と分子発生論
    　?．メラノーマの遺伝子異常
    　II． 母斑の遺伝子異常
    　III． 母斑とメラノーマの分子発生論
    　IV． メラノーマ・母斑の補助診断法としての遺伝子解析

    付録
    　? メラノーマの病理組織診断における記載事項
    　II tumor thicknessの定義と計測法
    　III メラノーマ診療に役立つガイドライン・URL　

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

A メラノーマと色素細胞母斑の本態・分類・診断

P.38 掲載の参考文献
1) Allen AC : A reorientation on the histogenesis and clinical significance of cutaneous nevi and melanomas. Cancer 2 : 28-56, 1949
PubMed
2) Clark WH, Jr et al. : Origin of familial malignant melanomas from heritable melanocytic lesions : the B-K mole syndrome. Arch Dermatol 114 : 723-728, 1978
 
3) Elder DE, et al. : Dysplastic nevus syndrome : a phenotypic association of sporadic cutaneous melanoma. Cancer 46 : 1787-1794, 1980
PubMed
4) Ackerman AB : Malignant melanoma in situ : the flat, curable stages of malignant melanoma. Pathology 17 : 298-300, 1985
PubMed
5) Ackerman AB : What naevus is dysplastic, a syndrome, and the commonest precursor of malignant melanoma? a riddle and an answer. Histopathology 13 : 241-245, 1988
 
6) Saida T : The concept of de novo origin of cutaneous malignant melanoma. Eur J Dermatol 4 : 252-254, 1994
 
7) Harada K, Ackerman AB : Less than 10% of primary cutaneous melanomas, worldwide, are associated with a melanocytic nevus and that nevus usually is congenital, not "dysplastic". Dermatopathology : Practical & Conceptual. 2005 ; 11 (2) : 3. http://derm101.com/content/32373 ; accessed May 1, 2012
 
8) Alendar T, Kittler H : Nevus associated versus "de novo" melanomas : a dermatoscopic-dermatopathologic study. 7th World Congress on Melanoma, May 12-16, 2009, Vienna, Austria
 
9) Clark WH, Jr et al. : Human Malignant Melanoma. Grune & Stratton, NY, 1979
 
10) Curtin JA et al. : Distinct sets of genetic alterations in melanoma. N Engl J Med 353 : 2135-2147, 2005
PubMed
11) Clark WH Jr et al. : A study of tumor progression : the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15 : 1147-1165, 1984
PubMed
12) Saida T, Ohshima Y : Clinical and histopathologic characteristics of early lesions of subungual malignant melanoma. Cancer 63 : 556-560, 1989
PubMed
13) Ackerman AB : Malignant melanoma : a unifying concept. Hum Pathol 11 : 591-595, 1980
PubMed
14) Bastian BC et al. : Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163 : 1765-1770, 2003
PubMed
15) Phan A et al. : Acral lentiginous melanoma : a clinicoprognostic study of 126 cases. Br J Dermatol 155 : 561-569, 2006
PubMed
16) Choi YD et al. : Amelanotic acral melanoma : clinicopathological, BRAF mutation, and KIT aberration analyses. J Am Acd Dermatol 69 : 700-707, 2013
 
17) Longo C et al. : Dermoscopy and confocal microscopy of nested melanoma of the elderly : recognizing a newly defined entity. JAMA Dermatol 149 : 941-945, 2013
PubMed
18) Garbe C, Metzler G : Nested melanoma, a newly defined entity. JAMA Dermatol 149 : 905-906, 2013
PubMed
19) Kutzner H et al. : Histological and genetic evidence for a variant of superficial spreading melanoma composed predominantly of large nests. Mod Pathol 25 : 838-845, 2012
PubMed
20) Pennacchia I et al. : Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma). Virchows Arch 461 : 433-439, 2012
PubMed
21) Murali R, et al. : Blue nevi and related lesions : a review high ighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol 16 : 365-382, 2009
 
22) Zembowicz A, et al. : Pigmented epithelioid meanocytoma : a low-grade melanocytic tumor with metastatic potential indistinguishable from animaltype melanoma and epithelioid blue nevus. Am J Surg Pathol 28 : 31-40, 2004
PubMed
23) Urso C, et al. : Animal-type melanoma : report of five cases with sentinel node biopsy and fluorescence in-situ hybridization analysis. Melanoma Res 24 : 47-53, 2014
PubMed
24) Mandal RV, et al. : Pigmented epithelioid melanocytoma : favorable outcome after 5-year follow-up. Am J Surg Pathol 33 : 1778-1782, 2009
PubMed
25) Zembowicz A, et al. : Loss of expression of protein kinase A regulatory subunit 1 alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol 31 : 1764-1775, 2007
PubMed
P.117 掲載の参考文献
1) Happle R : What is a nevus? a proposed definition of a common medical term. Dermatology 191 : 1-5, 1995
PubMed
2) Unna PG : Naevi und Naevocarcinome. Berl Klin Wochenschr 30 : 14-16, 1893
 
3) Masson P : My conception of cellular nevi. Cancer 4 : 9-38, 1951
PubMed
4) Kawamura T : Pathogenesis of nevus cells and genetic relationship between nevus pigmentosus, blue nevus, and Recklinghausen's phakomatosis. Hautarzt 7 : 7-14, 1956
PubMed
5) Mishima Y : Macromolecular changes in pigmentary disorders. Arch Dermatol 91 : 519-557, 1965
PubMed
6) Cramer SF : The histogenesis of acquired melanocytic nevi. based on a new concept of melanocytic differentiation. Am J Dermatopathol 6 (suppl 1) : 289-298, 1984
 
7) Magana-Garcia M, Ackerman AB : What are nevus cells? Am J Dermatopathol 12 : 93-102, 1990
PubMed
8) Zalaudek I, et al. : The epidermal and dermal origin of melanocytic tumors : theoretical considerations based on epidemiologic, clinical, and histopathologic findings. Am J Dermatopathol 30 : 403-406, 2008
PubMed
9) Kinsler VA, et al. : Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133 : 2229-2236, 2013
PubMed
10) Saida T : Histogenesis of congenital and acquired melanocytic nevi : a unifying concept. Am J Dermatopathol 28 : 377-379, 2006
PubMed
11) 斎田俊明 : 色素細胞母斑の統一概念. Visual Dermatol 2 : 1128-1136, 2003
 
12) Kopf AW, et al. : Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1 : 123-130, 1979
PubMed
13) Hidano A, et al. : Statistical survey of skin changes in Japanese neonates. Pediatr Dermatol 3 : 140-144, 1986
PubMed
14) Ackerman AB, Magana-Garcia M : Naming acquired melanocytic nevi. Unna's, Miescher's, Spitz's Clark's. Am J Dermatopathol 12 : 193-209, 1990
 
15) Cohen PR, Rapini RP : Nevus with cyst. A report of 93 cases. Am J Dermatopathol 15 : 229-234, 1993
PubMed
16) Arumi-Uria M, et al. : Grading of atypia in nevi : correlation with melanoma risk. Mod Pathol 16 : 764-771, 2003
PubMed
17) van Engen-van Grunsven AC, et al. : HRASmutated Spitz tumors : a subtype of Spitz tumors with distinct features. Am J Surg Pathol 34 : 1436-1441, 2010.
PubMed
18) Busam KJ, Barnhill RL : Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol 19 : 1061-1067, 1995
 
19) Harris K, et al. : Melanoma mimic : a case of multiple pagetoid Spitz nevi. Arch Dermatol 148 : 370-374, 2012.
 
20) Spatz A, et al. : Plexiform spitz nevus : an intradermal Spitz nevus with plexiform growth pattern. Am J Dermatopathol 21 : 542-546, 1999
PubMed
21) Barnhill RL, et al. : Plexiform spindle cell nevus : a distinctive variant of plexiform melanocytic naevus. Histopathology 18 : 243-247, 1991
PubMed
22) Smith KJ, et al. : Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol 13 : 931-939, 1989
PubMed
23) Barnhill RL, et al. : Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer 76 : 1833-1845, 1995
PubMed
24) Mones JM, Ackerman AB : "Atypical" Spitz's nevus, "malignant" Spitz's nevus, and "metastasizing" Spitz's nevus : a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 26 : 310-333, 2004
 
25) Urso C : A new perspective for spitz tumors? Am J Dermatopathol 27 : 364-366, 2005
PubMed
26) Ferrara G, et al. : Spitz nevus, Spitz tumor, and spitzoid melanoma : a comprehensive clinicopathologic overview. Dermatol Clin 31 : 589-598, 2013
PubMed
27) Cerroni L, et al. : Melanocytic tumors of uncertain malignant potential : results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 34 : 314-326, 2010
 
28) Caraco C, et al. : Sentinel lymph node biopsy in atypical Spitz nevi : Is it useful? Eur J Surg Oncol 38 : 932-935, 2012.
PubMed
29) Busam KJ, et al. : Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol 33 : 1386-1395, 2009.
PubMed
30) Wiesner T, et al. : Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43 : 1018-1021, 2011.
PubMed
31) Wiesner T, et al. : A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 36 : 818-830, 2012.
 
32) Argenziano G, et al. : Proposal of a new classification system for melanocytic naevi. Br J Dermatol 157 : 217-227, 2007
PubMed
33) Zalaudek I, et al. : A dual concept of nevogenesis : theoretical considerations based on dermoscopic features of melanocytic nevi. J Dtsch Dermatol Ges 5 : 985-992, 2007
PubMed
34) Hosler GA, et al. : Nevi with site-related atypia : a review of melanocytic nevi with atypical histologic features based on anatomic site. J Cutan Pathol 35 : 889-898, 2008
 
35) Saida T, Koga H : Dermoscopic patterns of acral melanocytic nevi : their variations, changes, and significance. Arch Dermatol 143 : 1423-1426, 2007
PubMed
36) Saida T, et al. : Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol 38 : 25-34, 2011.
PubMed
37) Minagawa A, Koga H, Saida T : Dermoscopic characteristics of congenital melanocytic nevi affecting acral volar skin. Arch Dermatol 147 : 809-813, 2011
PubMed
38) Kikuchi I, et al. : Regressing nevoid nail melanosis in childhood. Dermatology 186 : 88-93, 1993
PubMed
39) Ronger S, et al. : Dermoscopic examination of nail pigmentation. Arch Dermatol 138 : 1327-1333, 2002
PubMed
40) Gleason BC, et al. : Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol 32 : 51-57, 2008
 
41) Rongioletti F, et al. : Melanocytic nevi of the breast : A histologic case-control study. J Cutan Pathol 31 : 137-140, 2004
PubMed
42) Baran JL, Duncan LM : Combined melanocytic nevi : histologic variants and melanoma mimics. Am J Surg Pathol 35 : 1540-1548, 2011.
PubMed
43) 勝俣道夫, 他 : 続発性骨形成を伴った母斑細胞母斑自験10例 (11個) の臨床的, 病理組織学的検討. 皮膚臨床 35 : 1429-1436, 1993
 
44) Van Raamsdonk CD, et al. : Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457 : 599-602, 2009
PubMed
P.164 掲載の参考文献
1) 斎田俊明 : ダーモスコピーのすべて. 南江堂, 2012
 
2) Tschandl P, et al. : Accuracy of the first step of the dermatoscopic 2-step algorithm for pigmented skin lesion. Dermatol Pract Concept 2 : 43-49, 2012
 
3) Kittler H, et al. : Dermatoscopy : An Algorithmic Method Based on Pattern Analysis, Facultas WUV Universtatsverlag, Vienna, 2011
 
4) Saida T, et al. : Dermoscopy of pigmented lesions of the palms and soles. In : UpToDate, Tsao H, (ed), Waltham, MA, 2013
 
5) Ackerman AB, et al. : Pitfalls in Histopathologic Diagnosis of Malignant Melanoma. Lea & Febiger, Philadelphia, 1994
 
6) Hall BJ, LeBoit PE : Suprabasal spread of melanocytes in dysplastic nevi and melanoma in situ. Am J Surg Pathol 38 : 1111-1117, 2014
 

D 母斑とメラノーマの遺伝子異常と分子発生論

P.358 掲載の参考文献
1) Walia V, et al. : Delving into somatic variation in sporadic melanoma. Pigment Cell Melanoma Res 25 : 155-170, 2012
PubMed
2) Davies H, et al. : Mutations of the BRAF gene in human cancer. Nature 417 : 949-954, 2002
PubMed
3) Maldonado JL, et al. : Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95 : 1878-1890, 2003
PubMed
4) Pollock PM, et al. : High frequency of BRAF mutations in nevi. Nat Genet 33 : 19-20, 2003
 
5) Dankort D, et al. : Braf (V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41 : 544-552, 2009
PubMed
6) Dhomen N, et al. : Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15 : 294-303, 2009
PubMed
7) Flaherty KT, et al. : Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363 : 809-819, 2010
PubMed
8) Hauschild A, et al. : Dabrafenib in BRAF-mutated metastatic melanoma : a multicentre, open-label, phase 3 randomised controlled trial. Lancet 380 : 358-365, 2012
PubMed
9) Carr J, Mackie RM : Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol 131 : 72-77, 1994
 
10) Curtin JA, et al. : Distinct sets of genetic alterations in melanoma. N Engl J Med 353 : 2135-2147, 2005
PubMed
11) Curtin JA, et al. : Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24 : 4340-4346, 2006
PubMed
12) Carvajal RD, et al. : KIT as a therapeutic target in metastatic melanoma. JAMA 305 : 2327-2334, 2011
PubMed
13) Guo J, et al. : Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol 29 : 2904-2909, 2011
PubMed
14) Van Raamsdonk CD, et al. : Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457 : 599-602, 2009
PubMed
15) Van Raamsdonk CD, et al. : Mutations in GNA11 in uveal melanoma. N Engl J Med 363 : 2191-2199, 2010
PubMed
16) Zuo L, et al. : Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12 : 97-99, 1996
PubMed
17) Muthusamy V, et al. : Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes Cancer 45 : 447-454, 2006
PubMed
18) Sauter ER, et al. : Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 62 : 3200-3206, 2002
PubMed
19) Bastian BC, et al. : Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60 : 1968-1973, 2000
PubMed
20) Garraway LA, et al. : Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436 : 117-122, 2005
PubMed
21) Bertolotto C, et al. : A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480 : 94-98, 2011
PubMed
22) Yokoyama S, et al. : MITF pathway mutations in melanoma. Pigment Cell Melanoma Res 22 : 376-377, 2009
PubMed
23) Stahl JM, et al. : Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 64 : 7002-7010, 2004
PubMed
24) Davies MA, et al. : A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99 : 1265-1268, 2008
PubMed
25) Hodis E, et al. : A landscape of driver mutations in melanoma. Cell 150 : 251-263, 2012
PubMed
26) Krauthammer M, et al. : Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 44 : 1006-1014, 2012
PubMed
27) Huang FW, et al. : Highly recurrent TERT promoter mutations in human melanoma. Science 339 : 957-959, 2013
PubMed
28) Horn S, et al. : TERT promoter mutations in familial and sporadic melanoma. Science 339 : 959-961, 2013
PubMed
29) Li G, et al. : Downregulation of E-cadherin and desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 20 : 8125-8135, 2001
PubMed
30) Udayakumar D, et al. : EphA2 is a critical oncogene in melanoma. Oncogene 30 : 4921-4929, 2011
PubMed
31) Prickett TD, et al. : Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat Genet 41 : 1127-1132, 2009
PubMed
32) Dutton-Regester K, et al. : A high-throughput panel for identifying clinically relevant mutation profiles in melanoma. Mol Cancer Ther 11 : 888-897, 2012
PubMed
33) Pollock PM, et al. : Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 34 : 108-112, 2003
PubMed
34) Choi KY, et al. : Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci USA 108 : 15219-15224, 2011
PubMed
35) Prickett TD, et al. : Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet 43 : 1119-1126, 2011
PubMed
36) Wei X, et al. : Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43 : 442-446, 2011
PubMed
37) Hussussian CJ, et al. : Germline p16 mutations in familial melanoma. Nat Genet 8 : 15-21, 1994
PubMed
38) Kamb A, et al. : A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 : 436-440, 1994
PubMed
39) Nobori T, et al. : Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 : 753-756, 1994
PubMed
40) Aguissa-Toure AH, Li G : Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci 69 : 1475-1491, 2012
PubMed
41) Hocker T, Tsao H : Ultraviolet radiation and melanoma : a systematic review and analysis of reported sequence variants. Hum Mutat 28 : 578-588, 2007
PubMed
42) Freedberg DE, et al. : Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst 100 : 784-795, 2008
PubMed
43) Harbour JW, et al. : Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330 : 1410-1413, 2010
PubMed
44) Wiesner T, et al. : Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43 : 1018-1021, 2011
PubMed
45) Gibney T, Smalley K : An unholy alliance : cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistance. Cancer Discov 3 : 260-263, 2013
 
46) Kim M, et al. : Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125 : 1269-1281, 2006
PubMed
47) Goldberg SF, et al. : Melanoma metastasis suppression by chromosome 6 : evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 63 : 432-440, 2003
PubMed
48) Beck BH, Welch DR : The KISS1 metastasis suppressor : a good night kiss for disseminated cancer cells. Eur J Cancer 46 : 1283-1289, 2010
PubMed
49) Bastian BC, et al. : Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163 : 1765-1770, 2003
PubMed
50) Bauer J, et al. : Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol 127 : 179-182, 2007
PubMed
51) Ichii-Nakato N, et al. : High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 126 : 2111-2118, 2006
PubMed
52) Dessars B, et al. : Genotypic and gene expression studies in congenital melanocytic nevi : insight into initial steps of melanotumorigenesis. J Invest Dermatol 129 : 139-147, 2009
PubMed
53) Dessars B, et al. : Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi. J Invest Dermatol 127 : 1468-1470, 2007
PubMed
54) Bastian BC, et al. : Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 157 : 967-972, 2000
PubMed
55) Wiesner T, et al. : Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 3 : 3116, 2014
PubMed
56) Sini MC, et al. : Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma. Br J Dermatol 158 : 243-250, 2008
PubMed
57) Gray-Schopfer VC, et al. : Cellular senescence in naevi and immortalisation in melanoma : a role for p16?. Br J Cancer 95 : 496-505, 2006
PubMed
58) Michaloglou C, et al. : BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 : 720-724, 2005
PubMed
59) Lin J, et al. : Polyclonality of BRAF mutations in acquired melanocytic nevi. J Natl Cancer Inst 101 : 1423-1427, 2009
PubMed
60) Takata M, et al. : Molecular pathogenesis of malignant melanoma : a different perspective from the studies of melanocytic nevus and acral melanoma. Pigment Cell Melanoma Res 23 : 64-71, 2010
PubMed
61) Yeh I, et al. : Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. J Natl Cancer Inst 105 : 917-919, 2013
PubMed
62) Bennett DC : How to make a melanoma : what do we know of the primary clonal events? Pigment Melanoma Res 21 : 27-38, 2008
PubMed
63) Bennett DC : Human melanocyte senescence and melanoma susceptibility genes. Oncogene 22 : 3063-3069, 2003
PubMed
64) Michaloglou C, et al. : BRAF (E600) in benign and malignant human tumours. Oncogene 27 : 877-895, 2008
PubMed
65) Takata M : Genetic/epigenetic biomarkers : distinction of melanoma from other melanocytic neoplasms. in Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma, Murphy MJ ed, 2012, Springer, New York,. p.69-77
 
66) Gerami P, et al. : Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 33 : 1146-1156, 2009
PubMed
67) North JP, et al. : Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. Am J Surg Pathol 35 : 1146-1150, 2011
PubMed
68) Alexandrescu DT, et al. : Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis. J Invest Dermatol 130 : 1887-1892, 2010
PubMed
69) Kashani-Sabet M, et al. : A multi-marker assay to distinguish malignant melanomas from benign nevi. Proc Natl Acad Sci USA 106 : 6268-6272, 2009
 
70) Koh SS, et al. : Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue. Mod Pathol 22 : 538-546, 2009
PubMed
71) Talantov D, et al. : Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 11 : 7234-7242, 2005
 
72) Takata M, et al. : Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. Br J Dermatol 156 : 1287-1294, 2007
PubMed
73) Conway K, et al. : DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res 24 : 352-360, 2011
PubMed
74) Van Dijk MC, et al. : Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol 29 : 1145-1151, 2005
 
75) Takata M, Saida T : Genetic alterations in melanocytic tumors. J Dermatol Sci 43 : 1-10, 2006
PubMed
76) Harvell JD, et al. : High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas. Diagn Mol Pathol 13 : 22-25, 2004
PubMed
77) Takata M, et al. : Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA) : its usefulness as an adjunctive diagnostic tool for melanocytic tumors. J Dermatol Sci 40 : 51-57, 2005
PubMed
78) Gerami P, et al. : Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol 37 : 676-684, 2013
 
79) Raskin L, et al. : Copy number variations and clinical outcome in atypical spitz tumors. Am J Surg Pathol 35 : 243-252, 2011
PubMed
80) Wiesner T, et al. : A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 36 : 818-830, 2012
 
81) Yamaura M, et al. : Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ. Arch Dermatol 141 : 1413-1418, 2005
PubMed
82) Maize JC, Jr et al. : Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol 29 : 1214-1220, 2005
PubMed
83) Bastian BC, et al. : Genetic changes in neoplasms arising in congenital melanocytic nevi : differences between nodular proliferations and melanomas. Am J Pathol 161 : 1163-1169, 2002
PubMed

書評

最近チェックした商品履歴

Loading...